| 000 | 02358ngm a2200493 a 4500 | ||
|---|---|---|---|
| 001 | HST3754 | ||
| 003 | UkLoHST | ||
| 006 | m c | ||
| 007 | cr|cna|||a|||| | ||
| 007 | vz|czazum | ||
| 008 | 140722s2014 enk|||||||||||s|||v|eng d | ||
| 028 | 5 | 0 |
_a3754 _bHenry Stewart Talks |
| 035 | _a(UkLoHST)2817 | ||
| 040 |
_aUkLoHST _beng _cUkLoHST |
||
| 100 | 1 |
_aHauser, Robert A. _4spk |
|
| 245 | 1 | 0 |
_aPromising medical therapies for Parkinson's disease _h[electronic resource] / _cRobert A. Hauser. |
| 260 |
_aLondon : _bHenry Stewart Talks, _c2014. |
||
| 300 |
_a1 online resource (1 streaming video file (41 min.) : _bcolor, sound). |
||
| 490 | 1 |
_aParkinson's disease, _x2056-452X |
|
| 500 | _aAnimated audio-visual presentation with synchronized narration. | ||
| 500 | _aTitle from title frames. | ||
| 505 | 0 | _aContents: Selected Future Therapies for Motor Fluctuations and Dyskinesias -- Ankiparkinsonian agents -- A2a antagonists -- Levodopa preparations -- VR040 (inhaled apomorphine) -- Safinamide (mixed MOA : MAO-B and glu inhibition) -- Anti-dyskinetics -- AFQ056 : mGluR5 antagonist -- ADX48621 (dipraglurant) : mGluR5 negative allosteric modulator -- Fipamezole :a2 adrengergic receptor antagonist -- ADS-5102 : sustained release amantadine. | |
| 506 | _aAccess restricted to subscribers. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 650 | 0 |
_aAntiparkinsonian agents _xSide effects. |
|
| 650 | 0 | _aAntiparkinsonian agents. | |
| 650 | 0 |
_aDopa _xPhysiological effect. |
|
| 650 | 0 |
_aParkinson's disease _xChemotherapy. |
|
| 650 | 0 |
_aParkinson's disease _xTreatment. |
|
| 650 | 2 | _aAdenosine A2 Receptor Antagonists. | |
| 650 | 2 |
_aAntiparkinson Agents _xadverse effects. |
|
| 650 | 2 |
_aAntiparkinson Agents _xtherapeutic use. |
|
| 650 | 2 |
_aApomorphine _xpharmacokinetics. |
|
| 650 | 2 |
_aBenzylamines _xpharmacokinetics. |
|
| 650 | 2 | _aDopamine Agonists. | |
| 650 | 2 |
_aDyskinesia, Drug-Induced _xprevention & control. |
|
| 650 | 2 |
_aLevodopa _xtherapeutic use. |
|
| 650 | 2 |
_aParkinson Disease _xdrug therapy. |
|
| 650 | 2 |
_aParkinson Disease _xtherapy. |
|
| 650 | 2 |
_aReceptor, Metabotropic Glutamate 5 _xantagonists & inhibitors. |
|
| 830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pParkinson's disease. |
|
| 856 | 4 | 0 | _uhttps://hstalks.com/bs/2817/ |
| 856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/805/ _3Series |
| 999 |
_c77056 _d77056 |
||